Similarly, there was a nonsignificant trend towards lower serum levels of Flt3L in RA patients responding to adalimumab treatment (Figure 6 C).
← all excerpts
FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis.
2
—
—
The sentences
There was a trend towards higher Flt3L expression in mo-DC compared with monocytes but these differences did not reach statistical significance (Figure 5 A).